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Abstract
This study aimed to investigate associations between oxytocin receptor gene (OXT-R) polymorphisms (rs53576 and rs2254298), their
interaction with maternal care (GxE), and ED behaviours in a community sample. We studied 3698 women from the Avon Longitudinal
Study of Parents and Children (ALSPAC) who participated in a two-phase prevalence study of lifetime ED and had genotype data. The
GG rs53576 genotype was associated with binge eating and purging, and the rs2254298 AG/AA genotype with restrictive eating lifetime.
In addition, the rs2254298 AG/AA genotype interacted with poor maternal care to increase the odds of binge eating and purging
(odds ratio = 4.40 (95% conﬁdence intervals: 1.11–17.4)). This study replicates previous ﬁndings of an association between OXT-R
polymorphisms and ED, and it is the ﬁrst to show an interaction between OXT-R genotype and poor maternal care. As such, these
ﬁndings highlight the important role of oxytocin in understanding the pathophysiology of ED. © 2016 The Authors European Eating
Disorders Review published by Eating Disorders Association and John Wiley & Sons Ltd
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Introduction
There is increasing evidence that variations in levels and response
to the neuropeptide oxytocin are relevant to several psychiatric
disorders. In particular, research on the role of oxytocin on
cognition and behaviour has focused on autism spectrum disor-
ders, social behaviour, and emotional responses both in animals
and humans (Brune, 2012; Kawamura et al., 2010; Kirsch, 2015;
LoParo & Waldman, 2015; Saphire-Bernstein, Way, Kim,
Sherman, & Taylor, 2011).
In addition to differences in oxytocin levels, recent research has
focused on sensitivity to oxytocin. Variations in sensitivity to
oxytocin are thought to be the result of genetic and epigenetic
differences in the oxytocin receptor (OXT-R) gene. Genetic
polymorphisms of the OXT-R have received much attention in
relation to prosocial behaviour, empathy, and neuropsychiatric
disorders including autism spectrum disorders; in particular,
the most studied single nucleotide polymorphisms (SNPs) of the
OXT-R gene are rs53576 and rs2254298. For example, the
rs53576 GG genotype has been associated with higher levels of
empathy, lower levels of depression, and pro-social behaviour
(J. Li et al., 2015; Rodrigues, Saslow, Garcia, John, & Keltner,
2009). On the other hand, some studies have failed to show
similar associations (J. Li et al., 2015; Lucht et al., 2009; Wu, Li,
& Su, 2012). Similarly, rs2254298 genotypes have been associated
with sociability, affect, and temperament (Brune, 2012) and the
GG genotype in particular with lower plasma levels of circulating
oxytocin (Feldman et al., 2012). Although contrasting ﬁndings
have been reported as to which rs2254298 genotype might be
associated with psychopathology, there is evidence that having at
least one A allele (vs. G) on a 7-SNP haplotype block containing
rs2254298 is associated with higher depression scores (Kawamura
et al., 2010).
Given the role of oxytocin in afﬁliation, a number of studies
have addressed gene–environment interactions in relation to
OXT-R. Interactions between OXT-R polymorphisms and
childhood maltreatment have been shown in two studies, with
evidence of higher levels of emotional dysregulation in one study
(Bradley et al., 2011) and depression in a second study (McQuaid,
McInnis, Stead, Matheson, & Anisman, 2013) in carriers of the
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rs53576 GG genotype (Bradley et al., 2011) or G allele (McQuaid
et al., 2013) who also experienced childhood maltreatment.
Increasing evidence has highlighted a key role for oxytocin in
feeding behaviour (Leng et al., 2008) and appetitive control
(Sabatier, Leng, & Menzies, 2013). Early experiments showing
increases in food intake and weight as a result of brain lesions
affecting hypothalamic nuclei containing oxytocin (Leibowitz,
Hammer, & Chang, 1981) were compounded by studies in ani-
mals and humans demonstrating that exogenous oxytocin admin-
istration reduces caloric consumption, particularly of palatable
foods (Arletti, Benelli, & Bertolini, 1990; Lawson et al., 2015;
Maejima et al., 2015; Olson et al., 1991).
Given the role of oxytocin in feeding and eating behaviour,
oxytocin pathways have recently become a focus of study in eating
disorders (ED) (Monteleone, Scognamiglio, Volpe, Di Maso, &
Monteleone, 2016; Tortorella et al., 2014). Low basal
unstimulated serum oxytocin levels have been demonstrated in
low-weight, partially recovered, and weight-recovered women
with anorexia nervosa (AN) compared to healthy controls, sug-
gesting a potential etiologic role (Aﬁnogenova Y, in press; Lawson
et al., 2011; Lawson et al., 2012). Furthermore, postprandial levels
of oxytocin were correlated with the severity of ED psychopathol-
ogy and fMRI hypoactivation of relevant homestatic and hedonic
food motivation neural circuitry in AN (7). These data indicate
that abnormalities in oxytocin pathways persist in AN despite
weight recovery and are associated with abnormal neural activa-
tion, thoughts, and behaviours related to eating.
Two recent studies have investigated associations between
OXT-R genetic variants and ED. In particular, a Korean study
showed a positive association between the G allele of rs53576
and bulimia nervosa (BN) in a clinical sample of 90 women with
BN compared to controls (n=103) (Kim, Kim, Kim, Shin, &
Treasure, 2015). Amongst patients with AN, AN (weight-recov-
ered), BN and controls (overall n=124), subjects with rs53576
and rs2254298 GG/GG haplotype had lower scores on overall
ED psychopathology measures, less body shape and food preoccu-
pation, fewer obsessive compulsive behaviours, and lower anxiety
(Acevedo, Valencia, Lutter, & McAdams, 2015). A recent investi-
gation of women from the Avon Longitudinal Study of Parents
and Children (ALSPAC) sample showed that those with the
rs53576 GG genotype differed in terms of dietary intake and were
more likely to have endorsed having ever self-induced vomiting or
used laxatives for weight loss on a questionnaire at enrollment in
pregnancy (Connelly et al., 2014). Given the lack of signiﬁcant
‘hits’ in large genome wide studies (GWAS) of AN, a targeted
approach to speciﬁc polymorphisms might still prove fruitful in
our quest to clarify the neurobiology of ED.
Given a recent data collection of lifetime interview data on ED
amongst ALSPAC women (about 20 years after enrollment),
hence more precise phenotyping, and lack of availability of
information on other ED behaviours (binge-eating, restrictive
eating) in the previous study, we aimed to extend previous
ﬁndings by focusing on lifetime interview-collected ED
behaviours. This approach allowed us to investigate narrow ED
behavioural phenotypes that might be more closely associated
with speciﬁc genotypes, compared to heterogeneous diagnostic
syndromes, and the limited ED variables investigated in Connelly
et al. (2014).
To our knowledge, despite the well-known role of early
childhood adversity in increasing the risk for ED, no previous
studies have investigated gene–environment interactions between
OXT-R SNPs and poor parenting. We therefore aimed to deter-
mine: (i) whether polymorphisms in the OXT-R system genes
were associated with ED behaviours amongst adult women from
a community sample, and (ii) whether these polymorphisms
showed an interaction with poor maternal care in childhood.
We hypothesized that OXT-R gene polymorphisms, previously
shown to be associated with ED and ED behaviours, would be
associated with ED behaviours, in particular binge/purge type
behaviours in this community sample of women. Given the role
of OXT in afﬁliation and bonding, we expected an interaction
between OXT-R genotype and poor maternal care in increasing
the risk for ED behaviours.
Because of the known overlap and crossover of syndromes and
behaviours in ED, and the potential anorexigenic effect of OXT,
we were particularly interested in: (i) determining the associations
between OXT-R SNPs and speciﬁc ED behaviours (i.e. food
approach and compensatory behaviours vs. restrictive type
behaviours); and (ii) if any associations became evident, taking
into account the overlap between ED behaviours under study.
Materials and methods
Sample
ALSPAC is a longitudinal, population-based, extensive prospec-
tive study of women and their children, set up in the 1990s to
investigate the effects of environment, genetics, and other factors
on child health and development (Boyd et al., 2013; Golding,
Pembrey, Jones, & ALSPAC Team, 2001). All pregnant women
living in the geographical area of Avon, UK, who were expected
to deliver their baby between 1 April 1991 and 31 December
1992 were invited to take part in the study. ALSPAC recruited
14 541 pregnant women resident in Avon, UK with expected dates
of delivery 1 April 1991 to 31 December 1992. Of these initial
pregnancies, there was a total of 14 676 fetuses, resulting in
14 062 live births and 13 988 children who were alive at 1 year of
age. Women and their children have been followed up since.
Please note that the study website contains details of all the data
that is available through a fully searchable data dictionary:
<http://www.bris.ac.uk/alspac/researchers/data-access/data-dic-
tionary/>
Women who were still enrolled in the ALSPAC study in
2009/2010 took part in a two-phase sub-study to investigate the
prevalence of lifetime ED and ED behaviours (for details see
Micali et al., submitted). Amongst these, 5658 participated.
Detailed procedure and methods are described in Micali et al.
(submitted) and Kothari, Barona, Treasure, and Micali (2015).
ED behaviours
Data on ED behaviours were obtained using the ED section of the
Structured Clinical Interview for DSM-IV-TR disorders (SCID-I)
(First, Spitzer, Gibbon, & Williams, 2002), a semi-structured
interview to diagnose Axis I DSM-IV-TR disorders (American
Psychiatric Association, 2000). The SCID was supplemented with
a version of the LIFE interview (Keller et al., 1987) adapted to ED
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(Anderluh, Tchanturia, Rabe-Hesketh, Collier, & Treasure, 2009)
aimed at investigating presence, frequency and duration of ED
behaviours (restrictive eating, fasting, excessive exercise, binge
eating, and purging), and BMI over the life course (for details
see Micali et al., submitted). Women were asked to anchor their
responses using major events, such as the birth of their child or
other major life events in order to increase the accuracy of
reporting and minimize reporting bias. Each ED behaviour was
recorded over the lifetime from its ﬁrst occurrence to time of
the interview.
Lifetime ED behaviours: purging, restrictive eating, and binge
eating obtained from interviews were coded as binary variables.
Restrictive eating: women who had, at any time in their life,
engaged in dietary restriction or fasting to lose weight or to avoid
gaining weight (at a frequency of at least one whole day a week of
severe restriction or missing a minimum of three meals a week
(fasting) for a period of at least 3months), and had not engaged
at any point in their life in binge eating. Purging: women who
had, at any time in their life, engaged in purging behaviours (i.e.
vomiting/abuse of laxatives, diuretics, or slimming pills) at a
frequency of at least once a week for a period of at least 3months,
but had never engaged in restrictive eating. Binge-eating: women
who had, at any time in their life, engaged in binge eating
behaviours (overeating with loss of control) at a frequency of at
least once a week for a period of at least 3months, but had never
engaged in restrictive eating.
Three hundred and ninety-four (n=394) women reported any
of the ED behaviours above.
Given the high sensitivity (97.3%) of the Phase 1 screening
(Micali et al., submitted), all women who screened negative in
Phase 1 acted as controls (n=4708). Women who participated
to the ED sub-study were overall more likely to have received
secondary education and less likely to have had prior pregnancies
(Micali et al., submitted).
Maternal care
The Maternal care score was obtained from the maternal care
subscale of the Parental Bonding Instrument (PBI) (Parker,
Tupling, & Brown, 1979) completed by women at 18weeks
gestation, following enrollment in the ALSPAC cohort. This
instrument assesses the quality of relationships and bond with
both mother and father, up to 16 years of age, and has been shown
to be reliable and valid (Wilhelm, Niven, Parker, &
Hadzi-Pavlovic, 2005). The subscale included items that mea-
sured the woman’s perception of the relationship she had with
her own mother—the higher the score the warmer the relation-
ship. We categorized this variable as a binary variable, following
sensitivity analyses (Micali et al. submitted) qualifying the bottom
quartile (women with lowest scores), as those with poor maternal
care (received from their mother).
Genotyping
ALSPAC mothers were genotyped using the Illumina
Human660W-quad array at Centre National de Génotypage
(CNG), and genotypes were called with Illumina GenomeStudio.
PLINK (v1.07) was used to carry out quality control measures on
an initial set of 10 015 subjects and 557 124 directly genotyped
SNPs. SNPs were removed if they displayed more than 5%
missingness or a Hardy–Weinberg equilibrium p value of less than
1.0e 06. Additionally, SNPs with a minor allele frequency of less
than 1% were removed (Fatemifar et al., 2013). Samples were
excluded if they displayed more than 5% missingness, had
indeterminate X chromosome heterozygosity, or extreme autoso-
mal heterozygosity. Samples showing evidence of population
stratiﬁcation were identiﬁed by multidimensional scaling of
genome-wide identity by state pairwise distances using the four
HapMap populations as a reference, and then excluded. Related
subjects that passed quality control thresholds were retained
during subsequent phasing and imputation. Individuals were
imputed to HapMap Phase II (Build 36, release 22) using the
Markov Chain Haplotyping software (MACH v.1.0.16)(Y. Li,
Willer, Ding, Scheet, & Abecasis, 2010). Altogether, 9048 subjects
and 526 688 SNPs passed these quality control ﬁlters.
We studied two genetic polymorphisms in the OXT-R gene,
rs2254298 and rs53576; both have three levels that represent ge-
notypes GG, AG, and AA. The OXT-R gene is located on chromo-
some 3 p25. It spans 19 206 base-pairs and contains four exons
and three introns. Within this gene rs53576 and rs2254298 are
the two genetic variants (D′=0.64, r2= 0.024), situated in the
third intron, that have often been investigated. Although these
variants have not been found to have any clear functional impact
on the gene they may be in linkage disequilibrium with a yet
unidentiﬁed functional SNP (Connelly et al., 2014). As in
previous studies, we categorized the two genotypes into a
dichotomous variable (GG vs. A allele carrier, with AG and AA
combined) because of the small number of AA individuals.
Genotype distribution (and frequency) obtained for rs53576
was as follows: G/G (n=267, 48.8%), A/G (n=226, 41.3%),
and A/A(n=54, 9.9%) (MAF=0.41). This distribution does not
deviate from the Hardy–Weinberg equilibrium, χ2(1) = 0.369,
p=0.54. Genotype distribution (and frequency) obtained for
rs2254298 was: G/G (n=421, 77.0%), A/G (n=116, 21.2%), and
A/A(n=10, 1.8%) (MAF=0.214). This distribution does not
deviate from the Hardy–Weinberg equilibrium, χ2(1) = 0.369,
p=0.54. The genotype of rs2254298 was imputed using results
from the GWAS analysis. Validity of the imputation was
shown in Connelly et al. (2014).
In total, genotype results were available for 8330 and 8340
women for rs53576 and rs2254298.
Covariates
Body mass index (BMI) [weight (kg)/height(m)2] was obtained
from measured weight and height during a face to face assessment
carried out contemporaneously to the two-phase study. BMI was
available on 3504 women.
Ethical approval for the study was obtained from the ALSPAC
Ethics and Law Committee and the Local Research Ethics
Committees.
Statistical analyses
SNP and haplotype association analyses were performed with a
logistic regression model using the SNPstats programme (Sole,
Guino, Valls, Iniesta, & Moreno, 2006). All inheritance models
were evaluated, and the dominant model was found to be the best
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ﬁt in terms of the AIC for both rs53576 and rs2254298 (Leng
et al., 2008; Bakermans-Kranenburg & van Ijzendoorn, 2008).
We also tested the effect of the OXT-R genotypes in adjusted
logistic regression models where lifetime ED behaviours (binge
eating, purging, restrictive eating) were the outcomes, and BMI
was included as a covariate. Post-hoc analyses investigated the
effect of binge eating, purging, and their overlap (binge eating
and purging). Interaction analyses between OXT-R genotypes
and low maternal care were carried out including an interaction
term (GxE) as a predictor. Univariable, multivariable, and
interaction analyses were carried out in STATA 13.
Results
In total, data on ED behaviours was available on 5102 women,
and 3698 women had complete data on ED behaviours and had
valid genotype data. Missing data on BMI and maternal care
restricted the sample for multivariable analyses to 3135 women.
Women who had complete data on ED behaviours and genotype
were slightly older at enrollment (mean age = 29.6 (SD= 4.4)),
were more likely to have completed secondary education or
higher (50.4%) compared to those women who had missing data
on genotype (respectively, mean age = 29.2 (SD= 4.7), completed
A-levels or degree (40.3%)).
The OXT-R rs53576 A allele was negatively associated with
binge eating and purging (respectively: odds ratio (OR)= 0.52
(95%conﬁdence intervals (CI): 0.36–0.76), OR=0.66 (95%CI:
0.47–0.92)), suggesting a protective effect. In contrast, the
rs2254298 A allele was positively associated with purging behav-
iours (OR=1.50 (95%CI: 1.03–2.19), p=0.03) and restrictive
eating (OR=2.14 (95%CI: 1.42–3.23), p=5.1 × 104).
Haplotype association analyses showed that the rs53576
rs2254298 GA haplotype was positively associated with increased
odds of restrictive eating (OR=2.04 (1.41–2.96), p=2× 104)
and purging (OR=1.92 (1.06–3.47), p=0.03) (see Table 1).
In BMI-adjusted multivariable analyses, the rs53576 GG
genotype carriers had increased odds of binge eating (OR=1.91
(1.31–2.78), p=0.001) and purging (OR=1.55 (1.09–2.22),
p=0.01). Restrictive eating was not associated with rs53576
genotype (Table 3). The rs2254298 AG/AA genotype carriers had
increased odds of restrictive eating (OR=2.23 (1.42–3.49),
p< 0.0001), but not of binge eating or purging.
Poor maternal care was independently associated with both
binge eating and purging (respectively, OR= 1.65 (1.10–2.46),
p=0.01; OR=1.67 (1.02–2.72), p=0.04).
When the interaction term was added to the model, there was
no signiﬁcant interaction between OXT-R genotype for either
rs53576 and rs2254298 and poor maternal care in respect to all
Table 1 Associations between OXT-R haplotypes and ED behaviours amongst 3535 women
OXTR haplotypes Haplotype frequency Restrictive eating Binge eating Purging
OR (95%CI) p Valuea OR (95%CI) p Valuea OR (95%CI) p Valuea
rs53576 rs2254298
G G (n = 2019) 57% Ref. 0.99 × 10
3
Ref 0.006 Ref. 0.01
A G (n = 1119)
31.7%
0.89 (0.64–1.23)
p = 0.47
0.69 (0.51–0.94)
p = 0.02
0.84 (0.64–1.11)
p = 0.21
G A (n = 348)
9.9%
2.04 (1.41–2.96)
p = 2 × 10
4
1.17 (0.79–1.74)
p = 0.42
1.47 (1.03–2.08)
p = 0.03
A A (n = 47)
1.3%
N/A N/A N/A
ap Value for trend.
Bold indicates signiﬁcant associations.
Table 2 Logistic regression models of associations between ED behaviours and
rs53576 genotype and low maternal care (model 1), and their interaction
(model 2): odds ratios (and 95% conﬁdence intervals) adjusted by BMIa
amongst 3171 women
Restrictive eating
OR (95%CI)
Binge eating
OR (95%CI)
Purging
OR (95%CI)
Model 1
rs53576
GG genotypeb
1.50 (0.99–2.28) 1.91***(1.31–2.78) 1.55** (1.09–2.22)
Low maternal carec 1.64 (0.85–3.14) 1.40* (1.00–1.97) 1.41* (1.01–1.96)
Model 2
rs53576
GG genotypeb
1.43 (0.87–2.34) 1.52* (1.00–2.33) 1.62* (1.01–2.43)
Low maternal carec 1.24 (0.58–2.63) 1.38 (0.73–2.62) 1.76* (1.00–3.14)
rs53576
GG genotype × poor
maternal care
1.16 (0.42–3.17) 1.34 (0.59–3.06) 0.86 (0.39–1.87)
Model 1
rs2254298
AG/AA genotyped
2.23*** (1.42–3.49) 1.24 (0.81–1.93) 1.47 (0.97–2.23)
Poor maternal carec 1.41 (0.86–2.33) 1.76**(1.17–2.68) 1.53* (1.00–2.34)
Model 2
rs2254298
AG/AA genotyped
2.08**(1.23–3.49) 1.13 (0.67–1.91) 1.19 (0.72–1.96)
Poor maternal carec 1.28 (0.69–2.38) 1.62* (1.00–2.63) 1.22 (0.73–2.04)
rs2254298
AG/AA genotype × poor
maternal care
1.33 (0.47–3.79) 1.41 (0.54–3.65) 2.23 (0.89–5.62)
*p ≤ 0.05.
**p ≤ 0.01.
***p ≤ 0.001.
an = 3022 women with no lifetime ED behaviours are the referent group.
bAG/AA genotype is the referent group.
cLowest quartile vs. remaining 75%.
dGG genotype is the referent group.
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three outcomes (Table 2). There was a reduction in magnitude of
the effect of rs53576 GG genotype (vs. AA/AG genotype) in
relation to binge eating when including the interaction term
(Table 2). Similarly, the magnitude of the effect of rs2254298
genotype in relation to restrictive eating decreased when including
the interaction term.
Given the observed association between OXT-R genotypes and
binge/purge behaviours, post-hoc analyses explored the associa-
tion between the OXT-R rs53576 and rs2254298 genotypes, poor
maternal care and their interaction and the occurrence of binge
eating in the absence of purging, purging in the absence of binge
eating, and their overlap (binge eating and purging lifetime). As
shown in Table 3, rs53576 GG genotype carriers had two-fold in-
creased odds of having experienced both binge eating and purging
lifetime (OR=1.94 (1.13–3.34)) compared to AA/AG carriers, and
this association increased in magnitude when the interaction term
was included in the model (OR= 3.02 (1.43–6.38)); however, the
interaction between genotype and poor maternal care was not sig-
niﬁcant. In contrast, although there was a trend in rs2254298 A-
allele carriers having higher odds of both binge eating and purging,
the interaction between this genotype and poor maternal care was
signiﬁcant (p=0.03), and women with both the rs2254298 AG/AA
genotype and poor maternal care had a four-fold increased odds of
binge eating and purging (OR=4.40 (1.11–17.4)) (see Table 3).
Discussion
This study focused on investigating whether candidate genetic
variants in the oxytocin receptor system (OXT-R), well-studied
in the context of social behaviour, were associated with ED behav-
iours and interacted with poor maternal care in increasing the risk
for ED behaviours in a large population-based study of women
(ALSPAC). We focused on the two most studied SNPs in the oxy-
tocin receptor gene (rs2254298 and rs53576). Both rs2254298 and
rs53576 showed associations with ED behaviours. Women who
were homozygotes for the G allele in the rs53576 SNP were more
likely to have had lifetime binge eating and purging behaviours;
once we accounted for the co-occurrence of these behaviours, this
association became stronger. These ﬁndings are in line with ﬁnd-
ings from Kim et al (Kim, Kim et al., 2015), who showed an asso-
ciation between the same genotype and BN in a clinical sample.
Our ﬁndings also extend recent ﬁndings from ALSPAC (Connelly
et al., 2014) that highlighted an association between rs53576 GG
homozygosity and self-reported purging using a hypothesis-free
approach.
Association patterns between ED behaviours and rs2254298
differed compared to rs53576. The rs2254298 A allele carriers
were more likely to have experienced restrictive eating over their
lifetime. Although women with AA genotype did not have higher
odds of binge eating or purging, women with AG/AA genotypes in
the presence of poor maternal care had a four-fold increase in the
odds of binge eating and purging. The role of the two SNPs under
study was further corroborated by haplotype analyses showing
that women with the OXTR rs53576 rs2254298 GA haplotype
had increased odds of restrictive eating and purging.
There is increasing evidence that oxytocin is involved not only
in the regulation of food intake, but also in ED. Oxytocin secre-
tion has been shown to be dysregulated in low-weight and
weight-recovered individuals with AN (Aﬁnogenova et al., in
press; Lawson et al., 2011; Lawson et al., 2012). Moreover, abnor-
mal postprandial oxytocin levels in AN before and after weight
recovery are associated with reduced fMRI activation of food
motivation neural circuitry and increased severity of ED psycho-
pathology (Lawson et al., 2012). In addition to the evidence from
animal studies that oxytocin administration affects appetitive be-
haviour, oxytocin administration to healthy men reduced caloric
consumption, particularly of palatable foods (e.g. fats, carbohy-
drates) without changing subjective appetite, implicating reward
Table 3 Post-hoc associations between binge eating, purging and their co-occurrence, OXTR genotypes, low maternal care, and their interaction adjusted by BMI
(n = 3008)1
Binge eating and purging
(n = 83, 1.65%)
Binge eating
(n = 103, 2.05%)
Purging
(n = 124, 2.46%)
Controls
(n = 28232)
rs53576
GG genotype3
3.02 (1.43–6.38)
p = 0.004
1.37 (0.77–2.45)
p = 0.28
1.65 (0.92–2.95)
p = 0.09
Ref
Low maternal care4 1.84 (0.57–5.92)
p = 0.30
1.58 (0.69–3.57)
p = 0.27
2.23 (1.06–4.70)
p = 0.03
Ref
rs53576 GG genotype × low maternal care 0.87 (0.21–3.54)
p = 0.84
1.28 (0.43–3.77)
p = 0.65
0.31 (0.09–1.04)
p = 0.06
Ref
rs2254298 AG/AA
genotype5
1.18 (0.53–2.64)
p = 0.68
1.13 (0.57–2.23)
p = 0.72
1.28 (0.66–2.48)
p = 0.47
Ref
Low maternal care4 1.01 (0.41–2.48)
p = 0.97
2.09 (1.17–3.73)
p = 0.01
1.28 (0.66–2.49)
p = 0.46
Ref
rs2254298 AG/AA genotype × low maternal care 4.40 (1.11–17.4)
p = 0.03
0.42 (0.08–2.14)
p = 0.29
1.22 (0.32–4.68)
p = 0.77
Ref
1Behaviours are mutually exclusive; women with restrictive eating were excluded.
2Three women had missing data on rs2254298 genotype.
3AG/AA genotype is the referent group.
4Lowest quartile vs. remaining sample.
5GG genotype is the referent group.
Bold indicates signiﬁcant associations.
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pathways as potential candidate mechanisms (Kim, Eom, Yang,
Kang, & Treasure, 2015; Lawson et al., 2015; Ott et al., 2013).
The available literature on OXT-R genetic variants and behav-
iour, especially in relation to psychiatric outcomes, is mixed.
Some authors have hypothesized that mixed ﬁndings are a reﬂec-
tion of polymorphic variation in OXT-R genes not being a risk
marker per se, but markers of differential susceptibility once envi-
ronmental risk factors are included in the mix (Brune, 2012).
Therefore, although GG rs53576 homozygotes are usually consid-
ered to have higher empathy (Rodrigues et al., 2009), higher
optimism and self-esteem (Saphire-Bernstein et al., 2011), and
respond more sensitively to their children (Bakermans-
Kranenburg & van Ijzendoorn, 2008), they might also be ‘differ-
entially susceptible’ to adversity, that is, have better outcomes in
a nurturing environment but worse outcomes in the presence of
adversity. In fact, G allele carriers have been shown to be more
likely to develop depression and emotional dys-regulation in the
context of early adversity (Bradley et al., 2011; McQuaid et al.,
2013). Similarly, previous studies have shown an interaction be-
tween rs2254298 polymorphisms (A carriers) and early adversity
in respect to depressive symptoms, greater social anxiety, and
physical symptoms of anxiety (Thompson, Parker, Hallmayer,
Waugh, & Gotlib, 2011). Our study showed a similar effect mod-
iﬁcation in relation to bulimic symptoms.
Finally, although both SNPs under study are in intronic regions
of the OXT-R gene, not leading to functional changes in the OXT-
R, there is evidence that rs2254298 polymorphisms are associated
with biological differences. For example, lower plasma levels of
OXT have been identiﬁed amongst GG carriers (Feldman et al.,
2012). Volume of the amygdala has been shown to increase with
increasing number of A alleles of rs2254298 (Furman, Chen, &
Gotlib, 2011; Inoue et al., 1994). Functional and structural brain
differences of rs53576 polymorphisms were also highlighted
amongst healthy subjects, with GG homozygotes having higher
activation of the amygdala during a face emotion processing task,
and lower coupling of hypothalamus/amygdala connectivity (Tost
et al., 2010). It is possible that these intronic OXT-R gene
polymorphisms might therefore have a regulatory function, cause
altered splicing (Cooper, 2010), or inﬂuence transcriptional activ-
ity or methylation of nearby genomic regions (Cooper, 2010); or
that they might be a marker of a yet unidentiﬁed functional
polymorphism.
These ﬁndings need to be taken in context of relevant strengths
and limitations. There are several strengths to this study. First, it
relied on a large sample; second, the population-based nature of
the sample allowed us to focus on behaviours, likely to yield more
precise patterns of biological markers compared to diagnostic
syndromes (Anderluh et al., 2009). Data on ED behaviours were
collected using validated, well-tested instruments in mid life,
allowing us to capture presence of distinct ED behaviours and
their co-occurrence across most of the women’s life span. Data
on maternal care were obtained 20 years prior to the ascertain-
ment of ED behaviours, therefore decreasing the likelihood of
reporting bias. All analyses were adjusted by objectively measured
BMI, therefore ensuring that associations were not confounded by
BMI. Limitations include the relatively low prevalence of some
ED behaviours, leading to low power to detect small associations
and therefore possible false negatives. To be included in ALSPAC,
women had to be able to become pregnant; it is therefore possible
that this sample is representative of women with less severe ED.
However, as highlighted in (Micali et al., submitted), a range of
ED severity was evident across the sample. Similarly, our ﬁndings
might not generalize to all women; Connelly et al. (2014), how-
ever, found limited evidence of associations between the SNPs
under study and reproductive characteristics, suggesting that these
are unlikely to confound any association seen. We chose to focus
on maternal care as a more global measure of parenting rather
than more extreme forms of maltreatment, which have low prev-
alence and are more difﬁcult to ascertain; therefore, our ﬁndings
cannot be extrapolated to more severe maltreatment.
This study replicates and extends previous ﬁndings of an
association between OXTR gene polymorphisms and ED behav-
iours. It is the ﬁrst study to demonstrate an interaction between
poor maternal care and an OXT-R polymorphism (rs2254298)
in increasing the risk for bulimic type behaviours. Given our
increased understanding of the role of the oxytonergic system in
appetite and eating behaviour, these ﬁndings lay an important
foundation to further its study in the context of ED and eating
behaviours.
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